Protocol for a prospective, randomized study on neurophysiological assessment of lower urinary tract function in a healthy cohort

Stéphanie van der Lely, Martina Stefanovic, Melanie R Schmidhalter, Marta Pittavino, Reinhard Furrer, Martina D Liechti, Martin Schubert, Thomas M Kessler, Ulrich Mehnert, Stéphanie van der Lely, Martina Stefanovic, Melanie R Schmidhalter, Marta Pittavino, Reinhard Furrer, Martina D Liechti, Martin Schubert, Thomas M Kessler, Ulrich Mehnert

Abstract

Background: Lower urinary tract symptoms are highly prevalent and a large proportion of these symptoms are known to be associated with a dysfunction of the afferent pathways. Diagnostic tools for an objective and reproducible assessment of afferent nerve function of the lower urinary tract are missing. Previous studies showed first feasibility results of sensory evoked potential recordings following electrical stimulation of the lower urinary tract in healthy subjects and patients. Nevertheless, a refinement of the methodology is necessary.

Methods: This study is a prospective, randomized trial conducted at Balgrist University Hospital, Zürich, Switzerland. Ninety healthy subjects (forty females and fifty males) without lower urinary tract symptoms are planned to be included in the study. All subjects will undergo a screening visit (including standardized questionnaires, 3-day bladder diary, urinalysis, medical history taking, vital signs, physical examination, neuro-urological examination) followed by two measurement visits separated by an interval of 3 to 4 weeks. Electrical stimulations (0.5Hz-5Hz, bipolar, square wave, pulse width 1 ms) will be applied using a custom-made transurethral catheter at different locations of the lower urinary tract including bladder dome, trigone, proximal urethra, membranous urethra and distal urethra. Every subject will be randomly stimulated at one specific site of the lower urinary tract. Sensory evoked potentials (SEP) will be recorded using a 64-channel EEG cap. For an SEP segmental work-up we will place additional electrodes on the scalp (Cpz) and above the spine (C2 and L1). Visit two and three will be conducted identically for reliability assessment.

Discussion: The measurement of lower urinary tract SEPs elicited by electrical stimulation at different locations of the lower urinary tract has the potential to serve as a neurophysiological biomarker for lower urinary tract afferent nerve function in patients with lower urinary tract symptoms or disorders. For implementation of such a diagnostic tool into clinical practice, an optimized setup with efficient and reliable measurements and data acquisition is crucial. In addition, normative data from a larger cohort of healthy subjects would provide information on variability, potential confounding factors and cut-off values for investigations in patients with lower urinary tract dysfunction/symptoms.

Trial registration: Clinicaltrials.gov; Identifier: NCT02272309 .

Keywords: A-delta afferent fibers; Current perception threshold; Electrical stimulation; Electroencephalography; Lower urinary tract; Lower urinary tract dysfunction; Randomized; Sensory evoked potential; Urethra; Urinary bladder.

Figures

Fig. 1
Fig. 1
Example of a cortical LUT SEP recorded at Cz with the markers of the P1, N1 and P2 peaks and the corresponding latencies and peak-to-peak amplitudes
Fig. 2
Fig. 2
Study design and time schedule
Fig. 3
Fig. 3
Flowchart of the measurement visits (visits two and three)

References

    1. Coyne KS, Wein AJ, Tubaro A, Sexton CC, Thompson CL, Kopp ZS, Aiyer LP. The burden of lower urinary tract symptoms: evaluating the effect of LUTS on health-related quality of life, anxiety and depression: EpiLUTS. BJU Int. 2009;103(Suppl 3):4–11. doi: 10.1111/j.1464-410X.2009.08371.x.
    1. Irwin DE, Milsom I, Kopp Z, Abrams P, Cardozo L. Impact of overactive bladder symptoms on employment, social interactions and emotional well-being in six European countries. BJU Int. 2006;97(1):96–100. doi: 10.1111/j.1464-410X.2005.05889.x.
    1. Irwin DE, Kopp ZS, Agatep B, Milsom I, Abrams P. Worldwide prevalence estimates of lower urinary tract symptoms, overactive bladder, urinary incontinence and bladder outlet obstruction. BJU Int. 2011;108(7):1132–8. doi: 10.1111/j.1464-410X.2010.09993.x.
    1. Yoshimura N. Lower urinary tract symptoms (LUTS) and bladder afferent activity. Neurourol Urodyn. 2007;26(6 Suppl):908–13. doi: 10.1002/nau.20487.
    1. Fowler CJ. Bladder afferents and their role in the overactive bladder. Urology. 2002;59(5 Suppl 1):37–42. doi: 10.1016/S0090-4295(02)01544-3.
    1. Schafer W, Abrams P, Liao L, Mattiasson A, Pesce F, Spangberg A, Sterling AM, Zinner NR, van Kerrebroeck P, International Continence S. Good urodynamic practices: uroflowmetry, filling cystometry, and pressure-flow studies. Neurourol Urodyn. 2002;21(3):261–74. doi: 10.1002/nau.10066.
    1. Heeringa R, van Koeveringe GA, Winkens B, van Kerrebroeck PE, de Wachter SG. Degree of urge, perception of bladder fullness and bladder volume--how are they related? J Urol. 2011;186(4):1352–7. doi: 10.1016/j.juro.2011.05.050.
    1. Erdem E, Akbay E, Doruk E, Cayan S, Acar D, Ulusoy E. How reliable are bladder perceptions during cystometry? Neurourol Urodyn. 2004;23(4):306–9.
    1. De Wachter S, Van Meel TD, Wnydaele JJ. Can a faked cystometry deceive patients in their perception of filling sensations? A study on the reliability of spontaneously reported cystometric filling sensations in patients with non-neurogenic lower urinary tract dysfunction. Neurourol Urodyn. 2008;27(5):395–8. doi: 10.1002/nau.20523.
    1. Groen J, Pannek J, Castro Diaz D, Del Popolo G, Gross T, Hamid R, Karsenty G, Kessler TM, Schneider M, t Hoen L, et al. Summary of European Association of Urology (EAU) guidelines on Neuro-Urology. Eur Urol. 2016;69(2):324–33. doi: 10.1016/j.eururo.2015.07.071.
    1. Virseda M, Salinas J, Esteban M, Mendez S. Reliability of ambulatory urodynamics in patients with spinal cord injuries. Neurourol Urodyn. 2013;32(4):387–92. doi: 10.1002/nau.22303.
    1. Bellucci CH, Wollner J, Gregorini F, Birnbock D, Kozomara M, Mehnert U, Kessler TM. Neurogenic lower urinary tract dysfunction--do we need same session repeat urodynamic investigations? J Urol. 2012;187(4):1318–23. doi: 10.1016/j.juro.2011.11.107.
    1. Yarnitsky D. Quantitative sensory testing. Muscle Nerve. 1997;20(2):198–204. doi: 10.1002/(SICI)1097-4598(199702)20:2<198::AID-MUS10>;2-#.
    1. De Wachter S, Wyndaele JJ. Quest for standardisation of electrical sensory testing in the lower urinary tract: the influence of technique related factors on bladder electrical thresholds. Neurourol Urodyn. 2003;22(2):118–22. doi: 10.1002/nau.10017.
    1. De Laet K, De Wachter S, Wyndaele JJ. Current perception thresholds in the lower urinary tract: Sine- and square-wave currents studied in young healthy volunteers. Neurourol Urodyn. 2005;24(3):261–6. doi: 10.1002/nau.20095.
    1. Ulrich Mehnert, André Reitz, Maya Ziegler, Peter A. Knapp, Brigitte Schurch. Does Tolterodine Extended Release Affect the Bladder Electrical Perception Threshold? A Placebo Controlled, Double-Blind Study With 4 and 8 mg in Healthy Volunteers. The Journal of Urology. 2007;178(6):2495-2500.
    1. Ukimura O, Ushijima S, Honjo H, Iwata T, Suzuki K, Hirahara N, Okihara K, Mizutani Y, Kawauchi A, Miki T. Neuroselective current perception threshold evaluation of bladder mucosal sensory function. Eur Urol. 2004;45(1):70–6. doi: 10.1016/j.eururo.2003.08.004.
    1. Knupfer SC, Liechti MD, Gregorini F, De Wachter S, Kessler TM, Mehnert U. Sensory function assessment of the human male lower urinary tract using current perception thresholds. Neurourol Urodyn. 2016 [Epub ahead of print].
    1. Cruccu G, Aminoff MJ, Curio G, Guerit JM, Kakigi R, Mauguiere F, Rossini PM, Treede RD, Garcia-Larrea L. Recommendations for the clinical use of somatosensory-evoked potentials. Clin Neurophysiol. 2008;119(8):1705–19. doi: 10.1016/j.clinph.2008.03.016.
    1. Deltenre PF, Thiry AJ. Urinary bladder cortical evoked potentials in man: suitable stimulation techniques. Br J Urol. 1989;64(4):381–4. doi: 10.1111/j.1464-410X.1989.tb06047.x.
    1. Chiappa KH, Ropper AH. Evoked potentials in clinical medicine (first of two parts) N Engl J Med. 1982;306(19):1140–50. doi: 10.1056/NEJM198205133061904.
    1. Ganzer H, Madersbacher H, Rumpl E. Cortical evoked potentials by stimulation of the vesicourethral junction: clinical value and neurophysiological considerations. J Urol. 1991;146(1):118–23.
    1. Hansen MV, Ertekin C, Larsson LE. Cerebral evoked potentials after stimulation of the posterior urethra in man. Electroencephalogr Clin Neurophysiol. 1990;77(1):52–8. doi: 10.1016/0168-5597(90)90016-7.
    1. Sarica Y, Karacan I, Thornby JI, Hirshkowitz M. Cerebral responses evoked by stimulation of vesico-urethral junction in man: methodological evaluation of monopolar stimulation. Electroencephalogr Clin Neurophysiol. 1986;65(2):130–5. doi: 10.1016/0168-5597(86)90045-6.
    1. Gregorini F, Wollner J, Schubert M, Curt A, Kessler TM, Mehnert U. Sensory evoked potentials of the human lower urinary tract. J Urol. 2013;189(6):2179–85. doi: 10.1016/j.juro.2012.11.151.
    1. Flavia Gregorini, Stephanie C. Knüpfer, Martina D. Liechti, Martin Schubert, Armin Curt, Thomas M. Kessler, Ulrich Mehnert. Sensory evoked potentials of the bladder and urethra in middle-aged women: the effect of age. BJU International. 2015;115:18-25.
    1. Sarica Y, Karatas M, Bozdemir H, Karacan I. Cerebral responses elicited by stimulation of the vesico-urethral junction (VUJ) in diabetics. Electroencephalogr Clin Neurophysiol. 1996;100(1):55–61. doi: 10.1016/0168-5597(95)00203-0.
    1. Badr G, Carlsson CA, Fall M, Friberg S, Lindstrom L, Ohlsson B. Cortical evoked potentials following stimulation of the urinary bladder in man. Electroencephalogr Clin Neurophysiol. 1982;54(5):494–8. doi: 10.1016/0013-4694(82)90034-7.
    1. Hansen MV, Ertekin C, Larsson LE, Pedersen K. A neurophysiological study of patients undergoing radical prostatectomy. Scand J Urol Nephrol. 1989;23(4):267–73. doi: 10.3109/00365598909180336.
    1. Brookes ST, Donovan JL, Wright M, Jackson S, Abrams P. A scored form of the Bristol female lower urinary tract symptoms questionnaire: data from a randomized controlled trial of surgery for women with stress incontinence. Am J Obstet Gynecol. 2004;191(1):73–82. doi: 10.1016/j.ajog.2003.12.027.
    1. Donovan JL, Peters TJ, Abrams P, Brookes ST, de aa Rosette JJ, Schafer W. Scoring the short form ICSmaleSF questionnaire. International Continence Society. J Urol. 2000;164(6):1948–55. doi: 10.1016/S0022-5347(05)66926-1.
    1. Costa P, Perrouin-Verbe B, Colvez A, Didier J, Marquis P, Marrel A, Amarenco G, Espirac B, Leriche A. Quality of life in spinal cord injury patients with urinary difficulties. Development and validation of qualiveen. Eur Urol. 2001;39(1):107–13. doi: 10.1159/000052421.
    1. Barry MJ, Fowler FJ, Jr, O'Leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK, Cockett AT. The American Urological Association symptom index for benign prostatic hyperplasia. The measurement committee of the American Urological Association. J Urol. 1992;148(5):1549–57.
    1. Coyne KS, Thompson CL, Lai JS, Sexton CC. An overactive bladder symptom and health-related quality of life short-form: validation of the OAB-q SF. Neurourol Urodyn. 2015;34(3):255–63. doi: 10.1002/nau.22559.
    1. Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology. 1997;49(6):822–30. doi: 10.1016/S0090-4295(97)00238-0.
    1. Rosen R, Brown C, Heiman J, Leiblum S, Meston C, Shabsigh R, Ferguson D, D'Agostino R., Jr The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther. 2000;26(2):191–208. doi: 10.1080/009262300278597.
    1. Kelleher CJ, Cardozo LD, Khullar V, Salvatore S. A new questionnaire to assess the quality of life of urinary incontinent women. Br J Obstet Gynaecol. 1997;104(12):1374–9. doi: 10.1111/j.1471-0528.1997.tb11006.x.
    1. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361–70. doi: 10.1111/j.1600-0447.1983.tb09716.x.
    1. Nasreddine ZS, Phillips N, Chertkow H. Normative data for the Montreal Cognitive Assessment (MoCA) in a population-based sample. Neurology. 2012;78(10):765–6. doi: 10.1212/01.wnl.0000413072.54070.a3.
    1. Silverman BW. Some aspects of the spline smoothing approach to non-parametric regression curve fitting. J R Stat Soc B Methodol. 1985;47(1):1–52.
    1. Abraham B, Ledolter J. Introduction To Regression Modeling. 2006.
    1. Davidson AC, Hinkley DV. Bootstrap Methods and Their Application. Cambridge University Press. 1997;48.
    1. Efron B. Bootstrap methods: another look at the jackknife. Annals of Statistics. 1979;7(1):1–26. doi: 10.1214/aos/1176344552.
    1. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377–81. doi: 10.1016/j.jbi.2008.08.010.
    1. R Development Core Team. R. A Language and Environment for Statistical Computing. Vienna: R Foundation for Statistical Computing;2015.
    1. World Medical Association World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191–4. doi: 10.1001/jama.2013.281053.
    1. International conference on harmonisation. Good clinical practice guideline..
    1. Swiss Academy of Medical Sciences. Guideline-concerning scientific research involving human beings. 2009:. Accessed 22 Nov 2016.
    1. The Federal Authorities of the Swiss Confederation. Bundesgesetz über den Datenschutz (DSG) vom 19. Juni 1992, Stand. 01.01.2014. 1992: . Accessed 22 Nov 2016.

Source: PubMed

Sponsorzy i współpracownicy

Warunki medyczne

Interwencje lekowe

3
Subskrybuj